Single high oral dose amiodarone for cardioversion of recent onset atrial fibrillation

Heart, Lung & Circulation
Kugathasan Nadarasa, Michael J A Williams

Abstract

Selection of a pharmacological agent and mode of administration for cardioversion is a challenging task in recent onset atrial fibrillation. To report our experience using single high dose oral amiodarone for the cardioversion of recent onset atrial fibrillation to sinus rhythm in patient presenting with symptoms within 48 h. We retrospectively studied 48 patients with recent onset symptomatic atrial fibrillation presenting to the emergency department. These patients were admitted to the cardiology ward and treated with single high oral dose (30 mg/kg) amiodarone. The mean ± SD age of patients was 60.1 ± 4.4 years and 54% were male. Forty-two (90%) of them had symptoms <24h. The common risk factor for atrial fibrillation was hypertension (73%). Of 48 patients, 47 (98%) were chemically cardioverted to sinus rhythm in 6.3 ± 0.8h. The mean pre-treatment heart rate and blood pressure were 154/min and 159.3/88.0 mmHg. The lowest heart rate and blood pressure were 43/min and 122.5/80.9 mmHg respectively. High dose amiodarone was overall well tolerated except in three patients having self-limited gastrointestinal symptoms. Hospital discharge occurred in less than 24h after presentation in all but one patient. Single high dose oral ami...Continue Reading

References

Jan 1, 1995·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·P Di BiasiC Santoli
Apr 1, 1996·Journal of the American College of Cardiology·E GalveJ Soler-Soler
Nov 24, 1998·Pacing and Clinical Electrophysiology : PACE·G BorianiB Magnani
Dec 10, 1999·The Annals of Thoracic Surgery·K KatariyaH Bolooki
Jan 22, 2003·Journal of the American College of Cardiology·Philippe ChevalierPaul Touboul
May 28, 2003·International Journal of Cardiology·Ijaz A KhanRamesh M Gowda
May 12, 2006·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Jan Wilko SchrickelThorsten Lewalter
Sep 16, 2006·Heart·S J Russell, S Saltissi
Dec 7, 2006·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Hong Euy LimYoung-Hoon Kim
Sep 20, 2007·JAMA : the Journal of the American Medical Association·Patricia Vassallo, Richard G Trohman
Dec 9, 2008·British Medical Bulletin·Abhay BajpaiA John Camm
Oct 1, 2009·Postgraduate Medical Journal·N W F Linton, S W Dubrey

❮ Previous
Next ❯

Citations

Jun 28, 2019·Journal of Cardiovascular Medicine·Antonietta ForteleoniGuido Parodi
Jan 15, 2016·Deutsches Ärzteblatt International·Hermann H Klein, Hans-Joachim Trappe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.